Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewMycophenolate mofetil is an immunosuppressant prodrug of mycophenolic acid (MPA) (Cat. No. 1505). Hydrolyzed by esterases to release MPA, a reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). Used to prevent organ rejection after transplantation. Displays inhibitory activity of lymphocyte functions. Inhibits type 1 collagen expression, enhances MMP-1 expression, and reduces α-smooth muscle actin gene expression.
Mycophenolate mofetil is also offered as part of the Tocriscreen 2.0 Max, Tocriscreen Antiviral Library and Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.
M. Wt | 433.49 |
Formula | C23H31NO7 |
Storage | Store at RT |
Purity | ≥99% (HPLC) |
CAS Number | 128794-94-5 |
PubChem ID | 5281078 |
InChI Key | RTGDFNSFWBGLEC-SYZQJQIISA-N |
Smiles | O=C(OC2)C1=C2C(C)=C(OC)C(C/C=C(C)/CCC(OCCN3CCOCC3)=O)=C1O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 43.35 | 100 | |
ethanol | 4.33 | 10 |
The following data is based on the product molecular weight 433.49. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.31 mL | 11.53 mL | 23.07 mL |
5 mM | 0.46 mL | 2.31 mL | 4.61 mL |
10 mM | 0.23 mL | 1.15 mL | 2.31 mL |
50 mM | 0.05 mL | 0.23 mL | 0.46 mL |
References are publications that support the biological activity of the product.
Allison and Eugui (1996) Purine metabolism and immunosuppressive effects of mycophen. mofetil (MMF). Clin.Transplant. 10 77 PMID: 8680053
Roos et al (2007) In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophen. mofetil. J.Pharm.Exp.Ther. 321 583
If you know of a relevant reference for Mycophenolate mofetil, please let us know.
Keywords: Mycophenolate mofetil, Mycophenolate mofetil supplier, immunosuppressant, pro-drug, MMF, inhibits, inosine, monophosphate, dehydrogenase, IMPDH, Other, Dehydrogenases, Immunosuppressants, 4102, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Mycophenolate mofetil include:
Fikri Y et al (2022) Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice. Vaccine 40 854-861 PMID: 34991929
Do you know of a great paper that uses Mycophenolate mofetil from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Mycophenolate mofetil and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:
This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.